BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

French Regulator Investigated Over Servier Scandal


3/22/2013 7:33:40 AM

The scandal over a Servier Laboratories diabetes pill, which has been blamed for at least 500 deaths in France, has now ensnared the French regulatory agency. The ANSM has come under formal investigation for alleged involuntary manslaughter over concerns the agency neglected to respond to numerous reports that the Mediator drug, which was withdrawn four years ago, was causing serious harm. The move comes three months after Jacques Servier, the 90-year-old who founded Servier Laboratories, was also placed under investigation for involuntary manslaughter for allegedly misleading patients and authorities about the drug. In a statement, the ANSM promised to offer the “truth to which the victims, their families and users are entitled,” but also noted that the scandal occurred under its predecessor, AFSSAPS, and its functions were boosted last year as part of a reorganization. As we have written in previous stories, the probe focuses on suspicion of dishonest practices, deception over drug quality and falsely obtaining authorization to sell Mediator, which was often prescribed as an appetite suppressant for diabetics. Five companies under the Servier corporate umbrella are also under investigation. Servier is France’s second-largest drugmaker. The pill was linked to heart-valve damage and government investigators contended the risks were deliberately concealed. As many as 5 million people took the pill between 1976 and November 2009, when it was withdrawn in France, but that was several years after it was yanked in Spain and Italy. French health inspectors say Mediator should have been withdrawn a decade earlier.

Read at Pharmalot

Pharmalot
Servier
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->